Pharmacovigilance is a public health activity aimed at identifying, quantifying, evaluating and preventing the possible risks arising from the use of medicines.
Due to its very important role in maintaining the health of the population, pharmacovigilance activities must strictly follow current legislation.
The Spanish Agency for Medicines and Health Products (AEMPS) is the reference health authority for citizens and health professionals in terms of quality guarantees, safety, efficacy, information and accessibility of medications and health products.
The legislation in force in Spain is based on Law 29/2006 on guarantees and rational use of medicines and medical devices, modified in turn by Law 10/2013, of 24 July, and RD 577/2013, of 26 July, which regulates the pharmacovigilance of medicines for human use.
Do you want to report a suspected adverse reaction?
If you would like to report any signs, symptoms or diseases that you believe may be related to any of our medicines, please do so via email: [email protected]